September’s pain management coverage examined postoperative nonopioid options, lessons from sickle cell pain research, and pharmacists’ experiences with controlled-substance prescribing.
|Podcasts|April 6, 2023
Public Health Matters - Harm Reduction, SUD Treatment
Jeffrey Bratberg, PharmD, FAPhA, a clinical professor for the college of pharmacy at the University of Rhode Island, discusses harm reduction and substance use disorder treatment.
Advertisement
On this episode, Dr. Christina Madison, the Public Health Pharmacists, discusses harm reduction and substance use disorder treatment with Jeffrey Bratberg, PharmD, FAPhA, a clinical professor for the college of pharmacy at the University of Rhode Island and a pharmacists involved in harm reduction.
Advertisement
Related to this article
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
In a Pharmacy Times interview, study coauthor William J. Peppard, PharmD, discusses the association between suzetrigine and fewer opioid refills after knee replacement, the limits of the evidence, and the access barriers pharmacists can help patients navigate.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
3
What the 2025-2030 Dietary Guidelines Mean for Heart Health
4
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
5